Finding relationships between the overexpression APP, S100B, and IL-1β led to a series of experiments to explore mechanisms by which activation of glia and the resultant excess levels of neural IL-1β and S100B influence the neuropathogenesis of AD, as well as the AD of DS [98]. Here, IL1B is linked to Alzheimer disease.